Andrew Gengos

Affiliations

  • Chief Financial Officer at Terns Pharmaceuticals Inc. (TERN), 2025-06-16
  • Cfo And Chief Business Officer at Athira Pharma Inc. (ATHA), 2024-09-05
  • Chief Business Officer at Cyteir Therapeutics Inc. (CYT), 2022-02-24
  • Chief Operating Officer at Synlogic Inc. (SYBX), 2018-03-15
  • Director at Immunocellular Therapeutics Ltd. (IMUC), 2017-02-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TERN $3.95 5,000 $19,732.50 15,000 2025-06-16 Filing
TERN $3.72 5,000 $18,600.00 10,000 2025-06-13 Filing
TERN $3.75 5,000 $18,750.00 5,000 2025-06-13 Filing
ATHA $3.44 11,719 $40,307.50 80,012 2023-06-07 Filing
ATHA $3.40 2,859 $9,720.60 68,293 2023-06-07 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ATHA $0.57 1,272 $719.95 97,532 2024-09-05 Filing
ATHA $2.91 1,208 $3,515.28 83,804 2024-01-05 Filing
ATHA $2.91 1,208 $3,515.28 83,804 2023-01-05 Filing